Skip to main content

Anika Therapeutics, Inc 10-Q for FY2021 Q2

Anika Therapeutics, Inc. (ANIK)

10-Q 2021-08-06 For: 2021-06-30
View Original
Added on April 06, 2026

About this 10-Q

Anika Therapeutics, Inc filed this 10-Q on August 6, 2021, covering the quarter ended June 30, 2021 (FY2021 Q2).

Headline figures

Quarter ended June 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$38.15M
up 24.3% from $30.68M a year earlier
Net income
$6.53M
compared with a net loss of $7.71M a year earlier
Diluted EPS
$0.45
compared with -$0.54 a year earlier